The halogenated tetrahydro-β-carboline “TaClo”: A progressively-acting neurotoxin
“TaClo”, (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline) which is structurally very similar to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyri-dine), increases the sensitivity to apomorphine in aging rats after subchronic daily application (0.2 mg/kg i.p.) for 7 weeks. Nine weeks after the last treatment with TaClo, the running speed of the animals during spontaneous nocturnal activity was significantly diminished, and 9 months after the last injection rats developed a pronounced hypersensitivity to apomorphine (0.4 mg/kg s.c). TaClo, which can be readily produced from endogenous tryptamine and the non-natural aldehyde chloral, appears to be a drug that is able to induce a slowly-developing neurodegenerative process.
KeywordsChloral Hydrate Injection Period Postsynaptic Dopamine Receptor Minute Observation Period Striatal Dopaminergic System
Unable to display preview. Download preview PDF.
- Bringmann G, God R, Feineis D, Wesemann W, Riederer P, Rausch WD, Reichmann H, Sontag KH (1995) The TaClo concept: l-trichloromethyl-1,2,3,4-tetrahydro-β-carbo-line (TaClo) a new toxin for dopaminergic neurons. J Neural Transm [Suppl] 46: 235–244Google Scholar
- Grote C, Clement HW, Wesemann W, Bringmann G, Feineis D, Riederer, P, Sontag KH (1995) Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline) and derivatives. J Neural Transm [Suppl] 46: 275–281Google Scholar
- Janetzky B, God R, Bringmann G, Reichmann H (1995) 1-trichloromethyl-1,2,3,4-tetra-hydro-03B2-carboline, a new inhibitor of complex I. J Neural Transm [Suppl] 46: 265–273Google Scholar
- Rausch WD, Abdel-mohsen M, Koutsilieri E, Chan WW, Bringmann G (1995) Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-car-boline) in neural and glia cell cultures. J. Neural Transm [Suppl] 46: 255–263Google Scholar
- Sontag KH, Heim C, Sontag TA, God R, Reichmann H, Wesemann W, Rausch WD, Riederer P, Bringmann G (1995) Long-term behavioural effects of TaClo (1-tri-chloromethyl-1,2,3,4-tetrahydro-β-carboline) after subchronic treatment in rats. J Neural Transm [Suppl] 46: 283–289Google Scholar